At the end of Q1 2026, 29 institutions reported holding Aspire Biopharma Holdin-CW27 (ASBPW) in their 13F filings, unchanged from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Mint Tower Capital Management B.V. ($26K), Saba Capital Management, L.P. ($18K) and Adage Capital Partners Gp, L.L.C. ($17K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
Company
Aspire Biopharma Holdin-CW27
CUSIP
738920115
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
Institutions
Total Value
New Positions
1
$279
Exits
0
$0
All 13F filers, Q4 2025 → Q1 2026: 17,281 shares bought and 583,186 shares sold, net −565,905 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.